Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00744)

• Formulation Name: Alogliptin 25 mg tablet
• Company: Takeda Pharmaceuticals America

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Alogliptin	(DM8WI3R)	Type-2 diabetes	5A11	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butyl alcohol	(E00011)	263	Flavoring agent; Solvent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Eisenoxyd	(E00585)	56841934	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent